Creative Medical Technology Holdings (CELZ) Interest Coverage Ratio (2010 - 2023)
Creative Medical Technology Holdings' (CELZ) quarterly Interest Coverage Ratio came in at 22261.4 in Q1 2023, down 3631835.17% quarter-over-quarter from 0.61 in Q4 2021.
Analysis
Creative Medical Technology Holdings (CELZ) Interest Coverage Ratio (2010 - 2023) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Interest Coverage Ratio for 13 consecutive years, with 22261.4 the latest figure, recorded in Q1 2023.
- On a quarterly basis, Interest Coverage Ratio changed N/A year-over-year to 22261.4 in Q1 2023; TTM through Mar 2024 was 112604.18, a 44.82% increase from a year earlier, with the FY2021 full-year figure at 0.73, up 19.42% from the prior year.
- Interest Coverage Ratio was 22261.4 for Q1 2023 at Creative Medical Technology Holdings, down from 0.61 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.52 in Q3 2019 and troughed at 22261.4 in Q1 2023.
- A 4-year average of 1713.21 and a median of 0.81 in 2019 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio surged 48.33% in 2019 and slumped 205.95% in 2021, its largest moves.
- Over 4 years, Interest Coverage Ratio stood at 0.81 in 2019, then dropped by 24.71% to 1.01 in 2020, then soared by 39.41% to 0.61 in 2021, then slumped by 3631835.17% to 22261.4 in 2023.
- The last three Interest Coverage Ratio figures came in at 22261.4 (Q1 2023), 0.61 (Q4 2021), and 0.64 (Q3 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -0.01 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 9.95 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -3.63 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 7.67 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 2.71 |
| 10 | Creative Medical Technology Holdings | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -22,261.40 |
| Dec 31, 2021 | -0.61 |
| Sep 30, 2021 | -0.64 |
| Jun 30, 2021 | -2.20 |
| Mar 31, 2021 | -0.90 |
| Dec 31, 2020 | -1.01 |
| Sep 30, 2020 | -0.84 |
| Jun 30, 2020 | -0.72 |
| Mar 31, 2020 | -1.04 |
| Dec 31, 2019 | -0.81 |
| Sep 30, 2019 | -0.52 |
| Jun 30, 2019 | -0.55 |
| Mar 31, 2019 | -0.55 |
| Dec 31, 2018 | -0.84 |
| Sep 30, 2018 | -0.73 |
| Jun 30, 2018 | -0.76 |
| Mar 31, 2018 | -1.07 |
| Dec 31, 2017 | -1.35 |
| Sep 30, 2017 | -2.27 |
| Jun 30, 2017 | -6.26 |